Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals)
Source: SeekingAlpha
2026-02-26 09:23:12 ET
Mirum Pharmaceuticals ( MIRM ) just reported its 4Q, its full year topline clocking in at $521 million , up 55% from the prior year. Though the quarter's net income disappointed, the call cemented a banner year and provided investors with further insights into its widening slate of pipeline drugs. ...
Read the full article on Seeking Alpha
For further details see:
Mirum Pharmaceuticals: Nothing Stops This Train (But The Technicals)
Mirum Pharmaceuticals Inc.
NASDAQ: MIRM
MIRM Trading
2.72% G/L:
$89.53 Last:
255,649 Volume:
$88.05 Open:
MIRM Latest News
March 05, 2026 08:00:00 am
Mirum Pharmaceuticals Provides AZURE Clinical Program Update for brelovitug in Chronic Hepatitis Delta Virus
MIRM Stock Data
$5,184,583,745
44,013,457
0.43%
119
N/A
Biotechnology & Life Sciences
Healthcare
US
Foster City
